Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Hyperfine, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of HYPR: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders4352+9
Shares10.9M15.5M+4.60M (+42.0%)
Value$15.9M$15.2M−$662.7K (−4.2%)

New holders (12)

Institutions that held Hyperfine, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to HYPR in Q4 2025
InstitutionSharesValue% of portfolio
Sio Capital Management, LLC2,000,000$1.96M0.32%
Walleye Capital LLC216,658$212.2K0.00%
Cerity Partners LLC60,000$58.8K0.00%
Millennium Management LLC56,272$55.1K0.00%
Kathmere Capital Management, LLC51,813$50.7K0.00%
Gsa Capital Partners LLP49,409$48.0K0.00%
EP Wealth Advisors, LLC34,725$34.0K0.00%
Virtu Financial LLC18,710$18.0K0.00%
Morgan Stanley12,000$11.8K0.00%
Citadel Advisors LLC10,992$10.8K0.00%
49 Wealth Management, LLC10,000$9.79K0.00%
Simplex Trading, LLC1,787$1.75K0.00%

Sold out (3)

Institutions that held Hyperfine, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of HYPR in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Royal Bank of Canada31,200$45.0K
Two Sigma Securities, LLC19,775$28.7K
Citigroup Inc1$1